866-997-4948(US-Canada Toll Free)

Antibody Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Category :

3D

Antibodies are referred as proteins produced by plasma cells of the body which are used by immune system to identify and fight against foreign bodies entering the host body. Antibodies are also known as immunoglobulin (Ig). Antibodies are of Y shaped with specific binding site for specific antigen, a foreign body that provokes an adaptive immune response. Antibodies are secreted by type of white blood cells (WBCs) namely, plasma cells.

Immunity strength is observed to be directly proportional to age. With aging of population, the number of patients suffering diseases caused by weak immunity is increasing. Thus, factors such as global increase in the geriatric population, increasing research and development activity in the immunology field and availability of the government funds for research activities are driving the global antibody technologies market towards growth. On the other hand, lack of funds in developing economies, stringent regulatory framework and poor adoption of new technologies are some of the factors restraining the growth of the global antibody technologies market. Based on the type of antibody, the global antibody technologies market is segmented as follows:

  • Intravenous immunoglobulin (IVIg)
  • Microantibody
  • Single-domain antibody
  • Anti-mitochondrial antibodies
  • Secondary antibodies
  • Monoclonal antibody (mAb or moAb)
  • Anti-nuclear antibodies
  • Neutralizing antibody
  • Others

Based on applications, the global antibody technologies market is segmented as follows:

  • Medical application
    • Disease diagnosis
    • Therapy
      • Prenatal therapy
      • Immunotherapy
      • Antibody therapy
  • Research applications
    • Proteins
    • Flow cytometry
    • Immunoprecipitation
    • Immunochemistry
    • Immunoprecipitation
    • Immunofluorescence
  • Others

On the grounds of increased research and development activities globally, immunofluorescence is the fastest growing segment among the available research applications. Disease diagnosis segment is leading the medical application segment due to advancements in research and thereby entry of improved techniques in the market. Monoclonal antibodies (mAb or moAb) is leading the segment and is followed by Intravenous immunoglobulin (IVIg) in the antibody type based antibody technology segment.

Geographically, the global antibody technologies market is categorized into North America, Europe, Asia-Pacific and rest of the world regions. North America currently leads global antibody technologies market and is followed by Europe. Factors that are fueling the growth of antibody technology market in the North America include existence of highly advanced technologies, early adoption of new technologies, developed healthcare infrastructure and supportive economy. Asia-Pacific is a lucrative market for antigen technologies and is predicted to undergo fast market growth. Particularly, countries such as India and China show growth potential, owing to factors such as government support to develop biotechnology industry in respective countries, rapidly improving healthcare infrastructure and increased healthcare spending. In addition, Asia Pacific countries mainly India and China will attract patients on the grounds of rapidly developing medical tourism industry in these countries and thereby resulting in increased demand for antibody technologies market in this region.  Some of the major players contributing to the global antibody technologies market include, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Biotest AG, Shanghai RAAS Blood Products Co. Ltd., China Biologic Products, Inc., Bharat Serums and Vaccines Ltd., OMRIX Biopharmaceuticals Ltd., Kedrion S.p.A, Beijing Tiantan Biological Products Co. Ltd., Huanlan Biological Engineering, Inc., Guizhou Taibang Biological Products Co. Ltd., Grifols S.A., CSL Behring LLC, Baxter International, Inc. and Octapharma AG.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market      

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Please fill the Request TOC form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *